PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-03-02

Date Title Company
02-Mar-2022 FDA Approves Kaléo’s 10 mg Naloxone Auto-Injector for the Treatment of Known or Potential Exposure to Ultra-Potent Weaponized Opioids Businesswire
02-Mar-2022 Addus HomeCare Promotes Monica Raines To Executive Vice President, Chief Compliance and Quality Officer Businesswire
02-Mar-2022 NCCN Clinical Practice Guidelines in Oncology Update Recommends BESREMi® (ropeginterferon alfa-2b-njft) for the Treatment of Polycythemia Vera Businesswire
02-Mar-2022 Innocoll Announces Positive Topline Results For XARACOLL® (bupivacaine hydrochloride) implant in a Phase 3 Study to Support Expanded Use Businesswire
02-Mar-2022 Product Development Company MiGenTra Announces Formation of International Advisory Board B3C newswire
02-Mar-2022 Graphite Bio Appoints Alethia Young as Chief Financial Officer Businesswire
02-Mar-2022 Xalud Therapeutics Doses First Patient in Phase 2a Trial of XT-150 for the Treatment of Facet Joint Osteoarthritis Pain Businesswire
02-Mar-2022 Revance to Participate in the Cowen 42nd Annual Health Care Conference Businesswire
02-Mar-2022 TruBiotics® Grows Its Family: New Baby Drops Feature Clinically Researched Probiotic Strain BB-12® Shown to Reduce Excessive Infant Crying and Fussing, and Increase Sleep Duration Businesswire
02-Mar-2022 Automated Contouring Radiotherapy Software Market Industry Analysis, Opportunities, Technology, Demand, Top Players and Growth Forecast 2028 MARKITWIRED
02-Mar-2022 Brazilian Hemorrhagic Fever (BzHF) Treatment Market is Booming Worldwide by 2028 | Growth, Share, Demand and Analysis Forecasts MARKITWIRED
02-Mar-2022 Tuberculosis Diagnostics Market COVID-19 Industry Analysis, Future Trends, Opportunity Growth, Regional Outlook and Forecast 2028 MARKITWIRED
02-Mar-2022 Unit-Dose Respiratory Medications Market Insights, New Innovations, Research and Growth Factor till 2028 MARKITWIRED
02-Mar-2022 Severe Acute Respiratory Syndrome Treatment Market Growth Analysis, Opportunities, Trends, Developments, And Forecast to 2028 MARKITWIRED
02-Mar-2022 Measurement Technology in Downstream Processing Market is anticipated to increase from an estimated US$ 3,772.4 Million in 2022 MARKITWIRED
02-Mar-2022 Varicella Zoster Infection Treatment Market expected to register a 4.2% CAGR by the end of 2027 MARKITWIRED
02-Mar-2022 GCC Syringes and Needles Market is expected to reach US$ 1.33 Billion by 2031 MARKITWIRED
02-Mar-2022 GCC Medical Gloves Market valuation is projected to reach US$ 340.3 Million by 2031 MARKITWIRED
02-Mar-2022 Teva Canada Welcomes Public Drug Plan Reimbursement by Alberta, Saskatchewan, Québec, Veteran Affairs Canada and the Non-Insured Health Benefits Program for Patients prescribed AJOVY® (fremanezumab) for the Preventive Treatment of Migraine in Adults Businesswire
02-Mar-2022 Teva Canada se réjouit du remboursement d’AJOVY(MD) (frémanezumab) par les régimes publics d’assurance médicaments de l’Alberta, de la Saskatchewan, du Québec ainsi que par le ACC et le Programme SSNA aux patients prescrit AJOVY(MD) Businesswire